I don’t believe it’s a stretch to say that the China initiative fell into Generex’ lap. Isn’t $1M up front tangible? Isn’t $5M for the licensing fee tangible? The greater plan was temporarily put on hold. If they come home with the money, we can’t complain.
I hope Joe gets in and out of China quickly, in good health, and with a signed contract in hand. Then we can tune in to our regularly scheduled programming. Maybe the China funds provide some leverage in finalizing the S-1. We went from the mid .50’s to $1.65 in a flash.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links